SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-009937
Filing Date
2022-05-16
Accepted
2022-05-16 07:11:30
Documents
65
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cgem-20220331.htm   iXBRL 10-Q 2750948
2 EX-31.1 cgem-ex31_1.htm EX-31.1 17231
3 EX-31.2 cgem-ex31_2.htm EX-31.2 17223
4 EX-32.1 cgem-ex32_1.htm EX-32.1 17522
  Complete submission text file 0000950170-22-009937.txt   10032492

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cgem-20220331_cal.xml EX-101.CAL 47225
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cgem-20220331_def.xml EX-101.DEF 152639
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cgem-20220331.xsd EX-101.SCH 58469
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cgem-20220331_lab.xml EX-101.LAB 410577
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cgem-20220331_pre.xml EX-101.PRE 296280
59 EXTRACTED XBRL INSTANCE DOCUMENT cgem-20220331_htm.xml XML 2209164
Mailing Address ONE MAIN STREET SUITE 520 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 520 CAMBRIDGE MA 02142 617-410-4650
Cullinan Oncology, Inc. (Filer) CIK: 0001789972 (see all company filings)

IRS No.: 813867811 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39856 | Film No.: 22925406
SIC: 2836 Biological Products, (No Diagnostic Substances)